Puma Biotechnology, Inc.
NASDAQ:PBYI
Overview | Financials
Company Name | Puma Biotechnology, Inc. |
Symbol | PBYI |
Currency | USD |
Price | 2.81 |
Market Cap | 137,936,437 |
Dividend Yield | 0% |
52-week-range | 2.23 - 7.73 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Alan H. Auerbach |
Website | https://www.pumabiotechnology.com |
An error occurred while fetching data.
About Puma Biotechnology, Inc.
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD